MannKind Corp (MNKD) - Stock price history

Stock price history of MannKind Corp from 2004 to 2025

Annual Stock Price Performance

Year	Performance
2025	-11.52%
2024	64.03%
2023	-30.13%
2022	18.43%
2021	35.71%
2020	140.77%
2019	9.32%
2018	-60.15%
2017	-26.35%
2016	-55.86%
2015	-74.29%
2014	-1.69%
2013	117.57%
2012	-8.33%
2011	-70.55%
2010	-10.34%
2009	148.16%
2008	-56.36%
2007	-50.74%
2006	46.58%
2005	-29.40%
2004	11.86%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Halozyme Therapeutics HALO	53,55 €	1.26%	🇺🇸 USA
Novo Nordisk NVO	41,92 €	5.80%	🇩🇰 Denmark
Merck MRK	83,44 €	0.75%	🇺🇸 USA
Eli Lilly LLY	849,26 €	1.16%	🇺🇸 USA
Nektar Therapeutics NKTR	49,35 €	-1.77%	🇺🇸 USA
Pfizer PFE	22,03 €	1.78%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for MannKind Corp (MNKD)